Jean Michel Mansuy, Pierre Gallian, Chloé Dimeglio, Karine Saune, Catherine Arnaud, Bertrand Pelletier, Pascal Morel, Dominique Legrand, Pierre Tiberghien, Jacques Izopet – 11 January 2016 – Most cases of hepatitis E viral (HEV) infection in developed countries are autochthonous. Nevertheless, the reported seroprevalence of HEV varies greatly depending on the geographical area and the performance of the immunoassay used.
Harel Dahari, Scot J. Cotler, Jordan J. Feld – 11 January 2016
Anthony Cousien, Sylvie Deuffic‐Burban, Yazdan Yazdanpanah – 11 January 2016
George Papatheodoridis, Ioannis Vlachogiannakos, Evangelos Cholongitas, Karsten Wursthorn, Christos Thomadakis, Giota Touloumi, Jörg Petersen – 11 January 2016 – The possibility of safe discontinuation of therapy with nucleos(t)ide analogues (NAs) remains one of the most controversial topics in the management of chronic hepatitis B. Therefore, we systematically reviewed the existing data on NA discontinuation in this setting and tried to identify factors affecting the probability of posttherapy remission.
Lei Zhao, Linda L. Wong, Xuetao Shi, Junfang Ji – 11 January 2016
Marco Fiore, Lorenzo Andreana, Sebastiano Leone – 11 January 2016
Seema S. Desai, Jason C. Tung, Vivian X. Zhou, James P. Grenert, Yann Malato, Milad Rezvani, Regina Español‐Suñer, Holger Willenbring, Valerie M. Weaver, Tammy T. Chang – 11 January 2016 – Matrix rigidity has important effects on cell behavior and is increased during liver fibrosis; however, its effect on primary hepatocyte function is unknown. We hypothesized that increased matrix rigidity in fibrotic livers would activate mechanotransduction in hepatocytes and lead to inhibition of liver‐specific functions.
Sahar Taba Taba Vakili, Roshni Kailar, Khalidur Rahman, Behtash Ghazi Nezami, Simon Musyoka Mwangi, Frank A. Anania, Shanthi Srinivasan – 30 December 2015 – Moderate macrovesicular steatosis (>30%), which is present in almost 50% of livers considered for transplantation, increases the risk of primary graft dysfunction. Our previously published data showed that glial cell line–derived neurotrophic factor (GDNF) is protective against high‐fat diet (HFD)–induced hepatic steatosis in mice.
Jesús Fortún, Alfonso Muriel, Pilar Martín‐Dávila, Miguel Montejo, Oscar Len, Julian Torre‐Cisneros, Jordi Carratalá, Patricia Muñoz, Maria Carmen Fariñas, Asunción Moreno, Gema Fresco, Josune Goikoetxea, Joan Gavaldá, Juan Carlos Pozo, Marta Bodro, Antonio Vena, Fernando Casafont, Carlos Cervera, José Tiago Silva, José M.